Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2018-08-09 | 2018-10-26 | 57779 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-09-26 | 2017-10-12 | 23550 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-12-12 | 2018-01-26 | 32520 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2019-02-06 | 2019-04-25 | 74867 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2019-05-22 | 2019-11-11 | 84532 |
| APO-CLOBAZAM | 10MG | TABLET | Resolved | 2021-11-12 | 2021-12-16 | 149155 |
| APO-CLOBAZAM | 10MG | TABLET | Resolved | 2018-01-17 | 2018-03-03 | 36271 |
| APO-CLOBAZAM | 10MG | TABLET | Resolved | 2018-05-08 | 2018-06-30 | 48838 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2019-05-15 | 2019-06-21 | 84122 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2019-11-20 | 2019-12-19 | 99290 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2020-06-04 | 2022-09-06 | 116527 |
| APO-CLONAZEPAM | 0.5MG | TABLET | Resolved | 2024-09-20 | 2025-02-14 | 238242 |
| APO-CLONAZEPAM | 2MG | TABLET | Resolved | 2024-11-07 | 2025-02-14 | 242202 |
| APO-CLONAZEPAM | .5MG | TABLET | Resolved | 2017-09-20 | 2018-09-09 | 22870 |
| APO-CLONAZEPAM | .5MG | TABLET | Resolved | 2017-09-21 | 2018-10-05 | 22970 |
| APO-CLONIDINE | 0.025MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19136 |
| APO-CLONIDINE TAB 0.1MG | .1MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18994 |
| APO-CLONIDINE TAB 0.2MG | .2MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18997 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-21 | 2023-05-06 | 189994 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-01-12 | 2024-03-15 | 215970 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |